Bioinformatic analysis tools were determinant to evaluate the role of a high expression of KDM3A (lysine demethylase 3A) and DCLK1 (doublecortin-like kinase 1) and reduced expression FXYD3 in lung cancer. The gene discussed is DCLK1; the disease is lung carcinoma.